Patent Expiry

Patent/Exclusivity Expiry: VAFSEO

Drug
VAFSEO

Other upcoming events for AKBA

Phase 3 ReadoutPhase 3 Topline: A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vada
Patent ExpiryPatent/Exclusivity Expiry: AURYXIA

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: VAFSEO — AKBA Patent Expiry | BioSniper